AI Proteins

AI Proteins is at Winter RosettaCon! We are looking forward to hearing about everyone's great work throughout the community. Tomorrow, Aransa Gri?en Mu?oz will be presenting some of the work she completed during her internship with us in her talk "Designing novel PET-degrading enzymes using deep-learning." We hope to connect with many of the attendees to learn more about your research and share a bit about what we're working on at AIP! Vitaliy Andrusyshyn Ben Meinen James Bowman

AI Proteins Appoints Dr. Phil Brandish as Chief Development Officer Learn more & get our take ?? https://lnkd.in/g9u5CBgv “Phil is a crucial addition to our leadership team, bringing extensive experience developing drugs, driving collaborations, and leading high-performing teams. Phil joins us at an exciting time, as our platform is churning out lead molecules that address highly-demanding therapeutic criteria at breakneck speed. Phil will lead our rigorous target selection and prioritization process in addition to our development efforts.” — Dr. chris bahl, President, CEO, and Founder at AI Proteins “I am thrilled and privileged to be joining forces with Chris and the extraordinary team of scientists at AI Proteins. The AI-based miniprotein discovery platform that they have created and reduced to practice presents an unparalleled opportunity. That is, to create impactful new therapeutics that precisely meet the design goals dictated by the disease biology and by what patients need.” — Dr. Philip Brandish, Chief Development Officer at AI Proteins #SoHCNews

?? Site Visit to AI Proteins – Explore Innovation in Biotech! ?? Join us for an exclusive tour of AI Proteins’ office and lab spaces, meet the founder and team, and gain insights into the biotech startup landscape. Whether you’re interested in scientific innovation, entrepreneurship, or career opportunities, this is a fantastic chance to connect and learn. A happy hour will follow the tour! ?? Date: Friday, March 14, 2025 ? Time: 3:00 – 6:00 PM (ET) ?? Location: 20 Overland St, Boston, MA 02215 ?? RSVP here: https://lnkd.in/ecGX4VRf Don’t miss this opportunity to explore cutting-edge biotech research, network with industry professionals, and learn about career paths in a fast-growing startup! #HarvardBiotechClub #AIProteins #BiotechInnovation #Networking #BiotechStartups #LifeSciences #Entrepreneurship #CareerGrowth

Welcome Phil Brandish, Chief Development Officer, to the AI Proteins team! https://lnkd.in/eYVpFKFy

Looking for science that sounds like an 80s action movie? In December, Mireia Solà Colom presented an innovative approach to harness the immune system for cancer treatment, exploring how engineered miniproteins can enhance natural killer (NK) cell targeting, potentially leading to more effective and precise therapies. It's riveting! And be sure to check out Boston Protein Design and Modeling Club's channel for more of the latest in modeling.

We're very fortunate that we get to work with visionary investors like the folks at Tachyon Ventures!

We are proud to celebrate the work anniversaries of Tessa H., Julia A. Novina, Esq., and Mireia Solà Colom at AI Proteins. Their dedication and expertise are instrumental to our success, and we deeply appreciate their contributions. Tessa joined us in January 2023 as part of the Biochemistry team. Now a Senior Research Associate, she has played a key role in optimizing protein production for therapeutic research and leading our miniprotein production platform. When she’s not in the lab, you might find her scaling the Great Wall of China—twice and counting! Julia has been with the company since its beginning, officially joining as Chief Legal Officer in September 2021. As a founding executive, she has overseen legal operations, guiding the company’s growth through expertise in specialties such as technology licensing and contracting. Outside the office, she enjoys surfing, having recently traveled to beaches in Costa Rica! Mireia joined in January 2022 as a Scientist and now serves as Head of Immunotherapeutics. Her work in immunology has been pivotal in advancing key projects and collaborations driving innovative applications of protein therapeutics. She has presented AIP's latest research at multiple conferences, most recently sharing progress on miniprotein immune cell engagers at the Boston Protein Design and Modeling Club. Outside the lab, she’s often found rock climbing at her local gym. Their work continues to push the boundaries of protein therapeutics, and we’re excited to see all they accomplish in the years ahead!

Dr. chris bahl Appointed CEO of AI Proteins Learn more & get our take ?? https://lnkd.in/gKRAaHjw “I am honored and excited to take on the role of CEO at this pivotal time for AI Proteins. We have built a remarkable platform with the potential to unlock a new era of protein-based medicines.” — Dr. Chris Bahl, CEO at AI Proteins “Chris’ vision and expertise have been instrumental in establishing AI Proteins as a leader in AI-driven protein design.” — Drew Dennison, Managing Director at Lightchain Capital LLC #SoHCNews

We're delighted to share that our #Founder chris bahl is now our CEO!

Thrilled to celebrate Mireia, a brilliant scientist working at AI Proteins and pioneering the development of a new class of multifunctional immune cell engagers. By leveraging mini proteins, she is enabling precise engineering of the immune synapse, tailoring these engagers to specific cancers and their tumor microenvironments. The presentation is outstanding!